XML 59 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Equity (Tables)
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Share Based Payments Expense

The following table provides the details of the approximate total share-based payments expense during the year ended December 31, 2020, 2019, and 2018:

 

    For the Year Ended  
    December 31, 2020     December 31, 2019     December 31, 2018  
Employees and directors share-based payments   $ 298,000 (a)(c)   $ 494,000 (c)   $ 585,000 (c)
Stock options issued for services   $ 89,000 (d)   $ 67,000 (d)   $ 44,000 (d)
Shares issued for services   $ 357,000 (a)     19,000 (a)     -  
    $ 744,000     $ 580,000     $ 629,000
Summary of Stock Option Activity

Stock option activity for the year ended December 31, 2020, 2019 and 2018 is summarized as follows:

 

                Weighted Average        
                Remaining        
          Weighted     Contractual     Aggregated  
    Options     Average     Life     Intrinsic  
    Outstanding *     Exercise Price*     (Year)     Value  
Outstanding at January 1, 2018     486,333     $ 6.84       3.40     $ 996,860  
Exercised     (133,800 )     7.26       -       -  
Canceled     (18,833 )   $ 6.66       -       -  
Outstanding at December 31, 2018     333,700     $ 6.66       2.40     $ 188,790  
Exercised     -       -       -       -  
Canceled     (36,800 )   $ 6.90       -       -  
Outstanding at December 31, 2019     296,900     $ 6.66       1.4     $ -  
Granted     333,348       2.4       -       -  
Exercised     (294,733 )     6.66       -       -  
Canceled     (9,167 )   $ 3.48       -       -  
Outstanding at December 31, 2020     326,348       2.4       2.6     $ 143,587  
Vested and expected to be vested as of December 31, 2020     310,017       2.4       2.6       136,407  
Options exercisable as of December 31, 2020 (vested)     -       -       -       -  
Schedule of Non-vested Share Activity

The following table summarizes the status of options which contain vesting provisions:

 

          Weighted  
          Average  
          Grant Date  
    Options*     Fair Value*  
Non-vested at January 1, 2020     41,650     $ 3.54  
Granted     333,348     $ 1.01  
Vested     (41,650 )   $ 3.54  
Canceled     (7,000 )   $ 1.01  
Non-vested at December 31, 2020     326,348     $ 1.01
Schedule of Options Outstanding and Exercisable

The following table outlines the options outstanding and exercisable as of December 31, 2020:

 

    2020              
    Number of              
    Options              
    Outstanding     Exercise     Expiration  
    and Exercisable     Price     Date  
July 2020 stock options granted to certain consultants     57,366     $ 2.64       07/09/2023  
Total     57,366